- Rating
- 1
- Confidence
- 2
- Informativeness
- 1
- Presentation
- 2
- Soundness
- 1
Read review
Paper summary
This paper proposes a post-estimation framework for assessing the deployability of heterogeneous treatment policies by analyzing the topology of treatment-benefit regions. Using connected components and persistent homology, the method identifies stable beneficiary segments and evaluates whether they fit within deployment constraints. When the number of segments exceeds the available budget, it claims it can construct a conservative policy prioritizing the largest estimated gains.
Critical strengths
The paper considers a practical challenge in heterogeneous treatment effect estimation by considering the deployability of individualized treatment policies. The proposed topology-based framework provides a perspective on identifying stable beneficiary segments and quantifying policy complexity.
Critical weaknesses
First, existing constrained policy optimization methods can directly maximize expected reward subject to practical constraints, such as risk budgets or policy complexity restrictions. The motivation for introducing an additional post-estimation deployment stage is not sufficiently clear. The authors are encouraged to better distinguish the proposed framework from existing constrained policy learning approaches and clarify its unique advantages.
Second, the empirical evaluation is somewhat limited, particularly in its comparison with existing methods. Additional experiments comparing the proposed framework with constrained policy optimization and other deployment-aware approaches would help better demonstrate its effectiveness. A more detailed analysis of the performance differences would also strengthen the empirical findings.
Questions for authors
- Existing statistical literature has extensively studied constrained individualized treatment rule optimization, such as maximizing expected reward subject to risk, resource, or budget constraints. For example
Optimal individualized treatment rule for combination treatments under budget constraints (JRSSB, 2024)
Risk-aware restricted outcome learning for individualized treatment regimes of schizophrenia (AOAS 2024)
Estimating Individualized Treatment Rules with Risk Constraint (Biometrics, 2020)
It remains unclear why a separate post-estimation deployment stage is necessary rather than directly incorporating deployment constraints into policy optimization. Can authors clarify the additional benefits of the proposed framework compared with existing constrained optimization approaches?
- The empirical evaluation is not sufficiently comprehensive, particularly regarding comparisons with existing constrained policy learning methods with risk and budget constraints, and more complex setup in simulation studies. Including additional baselines would help demonstrate whether the proposed approach provides meaningful improvements over established methods. Also, are there any real data analysis to support the findings regarding to the deployment issue?